Blood pressure and comfort with transcutaneous hypoglossal nerve stimulation using the Zeus Sleep Device
Official title: Assessing Blood Pressure Variability in a Healthy Adult Population During Transcutaneous Hypoglossal Nerve Stimulation With the Zeus Sleep Device
Run by Royal Brompton & Harefield NHS Foundation Trust · NCT07917260 · Data updated 2026-11-12
This study tests whether using the Zeus Sleep Device to stimulate the hypoglossal nerve during sleep is safe in healthy adults and whether it affects blood pressure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Royal Brompton & Harefield NHS Foundation Trust Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | September 29, 2026 |
| Main results expected | February 19, 2027 |
| Study ends | March 29, 2027 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT07917260 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18+ in good health with BMI 18.5–29.9 kg/m2, no cardiovascular disease, no contraindications to the Zeus device, and the ability to consent.
✕Probably not a fit
Patients with cardiovascular disease, hypertension above 140/90 mmHg, arrhythmias, or other contraindications may not benefit and could be at higher risk.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study uses the Zeus Sleep Device to deliver transcutaneous hypoglossal nerve stimulation during sleep in healthy adults. The goal is to characterize any effects on blood pressure while assessing tolerability and safety in a population without obstructive sleep apnea. Participants will have device placement under the chin and will be monitored for cardiovascular and safety outcomes. The trial focuses on short-term exposure and includes clear exclusion criteria to minimize risk. Results will inform whether this approach can be pursued in patients with sleep-disordered breathing without adversely impacting blood pressure.
Why it matters
Potential benefit: If successful, the approach could inform safer use of transcutaneous hypoglossal nerve stimulation for sleep-related breathing issues and guide future patient-directed development.
How similar studies have gone: Previous studies suggest transcutaneous hypoglossal nerve stimulation is feasible and generally well tolerated; this study adds focused evaluation of blood pressure effects in healthy adults.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18 or older 2. Either biological sex 3. Healthy volunteers 4. Able to provide informed consent 5. No contraindications to hypoglossal nerve stimulation using the Zeus device 6. BMI \>18.5 and \<30kg/m2 Exclusion Criteria: 1. Skin allergy, including eczema or allergic contact dermatitis in device placement area 2. Diagnosed heart condition or cardiovascular disease 3. Cardiovascular event in the previous 2 months 4. Implanted medical devices including cardioverter defibrillator and pacemaker 5. Previous or current cardiac arrhythmia 6. Autonomic neuropathy 7. Neuromuscular disease 8. Diagnosed epilepsy or recurrent seizures 9. Hypertension (\>140/90 mmHg) 10. Hypotension (\<95/65 mmHg) 11. Metal work in the head or neck, excluding dental fillings 12. Current migraine 13. Pregnancy 14. Diagnosed or suspected deep vein thrombosis within previous 2 months 15. Recent cancer diagnosis or cancerous legions in proximity to device placement area 16. Alcohol dependence 17. Recent infection requiring hospital admission or medical treatment within the previous month, including leprosy 18. Swollen, inflamed, infected, or broken skin in device placement area 19. Recent surgery within 10 months in, or near, device placement area 20. Currently taking medications, excluding contraceptive medication 21. Long facial hair in device placement area
Where it's running
-
Royal Brompton Hospital
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Abigail Smart
- Email: abigail.smart@nhs.net
- Phone: 020 7351 8910
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ear-based vagus nerve stimulation to improve recovery after major noncardiac surgery
This test will try whether non-invasive ear (transcutaneous auricular) vagus nerve stimulation given around the time of major noncardiac surgery helps adults recover better.
-
Intraoral TENS to reduce orthodontic pain during alignment
This trial will test whether applying a small intraoral TENS device right after placing braces can reduce pain in adolescents and adults.
-
Effects of high frequency electrical current on muscle pain and function
This study is testing if a new type of electrical therapy called TECAR can help people with muscle pain and movement problems feel better compared to a standard treatment.
-
Using electrical stimulation to manage pain after cesarean delivery
This study is testing if a device that uses electrical stimulation can help women manage pain after having a cesarean delivery better than a placebo.
-
Vagus nerve stimulation to reduce pain and improve nerve function in diabetic neuropathy
This test tries non-invasive transcutaneous vagus nerve stimulation to reduce foot pain and improve nerve conduction and function in people aged 45–60 with diabetic peripheral neuropathy.
-
Transcutaneous Vagal Nerve Stimulation to help with brain vessel narrowing after aneurysm rupture
This trial tests whether using a noninvasive nerve stimulation device can reduce cerebral vasospasm after an aneurysmal brain bleed in adults 18–65 who are undergoing standard treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.